首页 | 本学科首页   官方微博 | 高级检索  
检索        


Recent Trends in the Treatment and Prognosis of Adult Leukemia with Characteristics of Patients in Japan: Transition during the Fifteen Years from 1971 to 1985
Authors:Suzuki  Hisamitsu; Ota  Kazuo; Ohno  Ryuzo; Masaoka  Toru; Shibata  Hirotoshi; Kimura  Ikuro; Amaki  Ichita; Miura  Yasusada; Uzuka  Yoshiro; Kawato  Masafumi; Shirakawa  Shigeru; Hirota  Yutaka; Maekawa  Tadashi; lmai  Kuniyuki; Takaku  Fumimaro; Shimoyama  Masanori; Kitahara  Takeshi; Oguro  Masao; Kozuru  Mitsuo; Kawagoe  Hiroya; Nakamura  Toru; Yamada  Kazumasa
Institution:1Department of Internal Medicine, Aichi Cancer Center Hospital 1-1, Kanokoden, Chikusa-ku, Nagoya 464
2First Department of Internal Medicine, Nagoya University, School of Medicine Osaka
3Department of Internal Medicine, Center for Adult Diseases Osaka
4Second Department of Internal Medicine, Okayama University, Medical School
5Department of Internal Medicine, Nihon University, School of Medicine
6Division of Hematology, Department of Medicine, Jichi Medical School, School of Medicine
7Third Department of Internal Medicine, Tohoku University, School of Medicine
8department of Internal Medicine, Second Tokyo National Hospital
9Second Department of Internal Medicine, School of Medicine, Mie University
10Department of Internal Medicine, National Nagoya Hospital
11Third Department of Internal Medicine, School of Medicine, Gunma University
12Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital
13Third Department of Internal Medicine, University of Tokyo, Faculty of Medicine
14Department of Internal Medicine, National Cancer Center Hospital
15Division of Hematology and Chemotherapy, Chiba Cancer Center Hospital
16Department of Hematology and Internal Medicine, National Kyushu Cancer Center Hospital
17Department of Internal Medicine, National Osaka Hospital
18Department of Internal Medicine, Fukui Medical School, Faculty of Medicine
19Department of Internal Medicine, Branch Hospital of Nagoya University, School of Medicine
Abstract:Patients with acute (2,569) and chronic (957) leukemia diagnosedat 19 institutes took part in the study on the "MultidisciplinaryTreatment of Leukemia" between 1971 and 1985 and were investigatedretrospectively. By dividing the 15 years into three five-yearperiods, we were able to compare patient ratios in the differentperiods. The proportions of acute to chronic leukemia casesshowed no obvious change; however, the proportions of casesdiagnosed as acute lymphocytic leukemia in acute leukemia showeda significant increase. The main chemotherapeutic drugs usedduring the three time periods were cytarabine or its analogues,the anthracyclines, 6-mercaputopurine and prednisolone, againstacute myelogenous leukemia, and the vinca alkaloids, prednisoloneand the anthracyclines against acute lymphocytic leukemia. Therate of complete remission from acute myelogenous leukemia mademarked progress, from 45.1% during 1971–1975 to 62.3%during 1981–1985, but that of acute lymphocytic leukemiashowed no significant progress, being 65% during 1971–1975and 69.7% during 1981–1985. The durations of remission,however, and the survival times for patients with acute lymphocyticleukemia, as well as for those with acute myelogenous leukemia,became significantly longer over the three periods. Median survivaltimes from chronic myelocytic leukemia were 37–40 mo inall three periods, showing no progress. There was a better prognosisin cases of chronic myelocytic leukemia with, than without,Philadelphia chromosome. Except for a low incidence of chroniclymphocytic leukemia in Japan, adult leukemia patients' characteristicsand prognoses seem to be almost the same in Japan as in theU.S.A. and Europe.
Keywords:Adult leukemia  Acute leukemia  Chronic leukemia  Incidence  Chemotherapy
本文献已被 Oxford 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号